Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Sartorius AG SOAGY OTC

Other OTC • Healthcare • Medical - Instruments & Supplies • DE • USD

SharesGrow Score
36/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Sartorius AG (SOAGY) — Analyst outlook / Analyst consensus target is. Based on 6 analyst ratings, the consensus is bullish — 1 Buy, 5 Hold.

SOAGY Analyst Ratings

Hold
6
Ratings
1 Buy
5 Hold
Based on 6 analysts giving stock ratings to Sartorius AG in the past 3 months
Rating breakdown
Buy
1 17%
Hold
5 83%
17%
Buy
1 analysts
83%
Hold
5 analysts
0%
Sell
0 analysts

People Also View

BDX
BDX
Becton, Dickinson and Company
$155.52
-0.13%
 RMD
RMD
ResMed Inc.
$228.80
-0.82%
 WST
WST
West Pharmaceutical Services, Inc.
$266.50
-0.53%
 STAA
STAA
STAAR Surgical Company
$24.73
+1.23%
 MBOT
MBOT
Microbot Medical Inc.
$2.39
-1.65%
 LLY
LLY
Eli Lilly and Company
$905.13
-1.88%
 JNJ
JNJ
Johnson & Johnson
$238.67
-0.60%
 ABBV
ABBV
AbbVie Inc.
$208.43
-0.87%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message